Medications

Origin of resistance to lung-cancer drug discovered

Researchers at Kanazawa University report in Nature Communications that AXL, a protein belonging to the class of receptor tyrosine kinases, causes some lung cancer patients to have an intrinsic resistance to the drug osimertinib. ...

Medical research

Novel biomarker in saliva linked to stress, resilience

(Medical Xpress)—Concerned about the effect of stress on your health and well-being? If your answer is "yes," then Arizona State University professor Doug Granger is doing research that could impact you. Granger is pioneering ...

Oncology & Cancer

Experimental drug beneficial in NIH trial to treat a rare sarcoma

(Medical Xpress)—Patients with advanced alveolar soft part sarcoma (ASPS), a rare cancer, achieved some control of their disease using an experimental anti-cancer drug called cediranib. The results from this largest clinical ...

Ophthalmology

Device designed to treat a leading cause of blindness

(Medical Xpress) -- Every year, more than 200,000 people in the U.S. are diagnosed with Wet Age-Related Macular Degeneration, a leading cause of blindness in Americans age 60 or older. There is no known cure for the disease, ...

page 38 from 40